Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.21.2
Fair Value Measurements (Tables)
 6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis

The following table sets forth the financial assets and liabilities carried at fair value measured on a recurring basis as of June 30, 2021 and December 31, 2020:

 

    Level 1     Level 2     Level 3     Total  
                         
As of December 31, 2020:                                
                                 

VisualMED Series B Preferred Stock

   $ -     $ -     $ -     $ -  
Embedded conversion option of debenture     -     $ -     $ 455,336     $ 455,336  
Total   $ -     $ -     $ 455,336     $ 455,336  
                                 
As of June 30, 2021:                                
VisualMED Series B Preferred Stock   $

-

     $

-

     $

8,500,000

     $

8,500,000

  
Embedded conversion option of debenture     -       -       455,336       455,336  
Total   $ -     $ -     $ 8,955,336     $ 8,955,336